Search research articles
Contact Us
Filters
Showing results (41-50 of 154) with videos related to
Page
of 16
Sort By:
The Journal of Pharmacology and Experimental Therapeutics
|
April 1, 1981
Disposition of morphine in rat brain: relationship to biological activity
G J Plomp, R A Maes, J M van Ree
International Journal of Clinical Pharmacology, Therapy, and Toxicology
|
June 1, 1983
Pharmacokinetics and pharmacodynamics of a short- and long-acting theophylline medication (theolair and Theolair retard) in normals and asthmatics. Part I: pharmacokinetics
I Utama, J Kreukniet, P G Meering, et al.
Psychopharmacology
|
July 31, 1998
Discriminative stimulus properties of mCPP: evidence for a 5-HT2C receptor mode of action
J Gommans, T H Hijzen, R A Maes, et al.
Veterinary and Human Toxicology
|
January 1, 1979
An evaluation of the use of hemoperfusion in acute poisoning
G de Groot, R A Maes, A N van Heijst
Pharmacy World & Science : PWS
|
December 1, 1996
Saliva as a specimen for therapeutic drug monitoring in pharmacies
J Zuidema, K M Höld, D de Boer, et al.
The Journal of Pharmacy and Pharmacology
|
June 30, 2000
Mono- and biphasic plasma concentration-time curves of mesalazine from a 500 mg suppository in healthy male volunteers controlled by the time of defecation before dosing
T B Vree, E Dammers, P S Exler, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
January 1, 1988
Application of the new ion trap detector in doping control
E G de Jong, R A Maes, J M van Rossum
Biomedical & Environmental Mass Spectrometry
|
October 1, 1988
Why do doping control labs need a tandem mass spectrometer?
E G de Jong, R A Maes, J M van Rossum
Journal of Chromatography. B, Biomedical Applications
|
January 6, 1995
Evaluation of the Salivette as sampling device for monitoring beta-adrenoceptor blocking drugs in saliva
K M Höld, D de Boer, J Zuidema, et al.
Nuklearmedizin. Nuclear Medicine
|
August 1, 1996
Radiochemical purity, at expiry, and radiochemical stability of iodine-131 labelled meta-iodobenzylguanidine concentrates for intravenous infusion
A R Wafelman, C A Hoefnagel, R A Maes, et al.
Page
of 16
Search research articles
Search
Showing results (41-50 of 154) with videos related to
Sort By:
Page
of 16
The Journal of Pharmacology and Experimental Therapeutics
|
April 1, 1981
Disposition of morphine in rat brain: relationship to biological activity
G J Plomp, R A Maes, J M van Ree
International Journal of Clinical Pharmacology, Therapy, and Toxicology
|
June 1, 1983
Pharmacokinetics and pharmacodynamics of a short- and long-acting theophylline medication (theolair and Theolair retard) in normals and asthmatics. Part I: pharmacokinetics
I Utama, J Kreukniet, P G Meering, et al.
Psychopharmacology
|
July 31, 1998
Discriminative stimulus properties of mCPP: evidence for a 5-HT2C receptor mode of action
J Gommans, T H Hijzen, R A Maes, et al.
Veterinary and Human Toxicology
|
January 1, 1979
An evaluation of the use of hemoperfusion in acute poisoning
G de Groot, R A Maes, A N van Heijst
Pharmacy World & Science : PWS
|
December 1, 1996
Saliva as a specimen for therapeutic drug monitoring in pharmacies
J Zuidema, K M Höld, D de Boer, et al.
The Journal of Pharmacy and Pharmacology
|
June 30, 2000
Mono- and biphasic plasma concentration-time curves of mesalazine from a 500 mg suppository in healthy male volunteers controlled by the time of defecation before dosing
T B Vree, E Dammers, P S Exler, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
January 1, 1988
Application of the new ion trap detector in doping control
E G de Jong, R A Maes, J M van Rossum
Biomedical & Environmental Mass Spectrometry
|
October 1, 1988
Why do doping control labs need a tandem mass spectrometer?
E G de Jong, R A Maes, J M van Rossum
Journal of Chromatography. B, Biomedical Applications
|
January 6, 1995
Evaluation of the Salivette as sampling device for monitoring beta-adrenoceptor blocking drugs in saliva
K M Höld, D de Boer, J Zuidema, et al.
Nuklearmedizin. Nuclear Medicine
|
August 1, 1996
Radiochemical purity, at expiry, and radiochemical stability of iodine-131 labelled meta-iodobenzylguanidine concentrates for intravenous infusion
A R Wafelman, C A Hoefnagel, R A Maes, et al.
Page
of 16